For Providers
myCOPD: Empowering providers to care for their whole population.
Empowering Healthcare Providers
We recognize the pivotal role that healthcare providers play in delivering optimal care for individuals with Chronic Obstructive Pulmonary Disease (COPD). Our platform is designed to seamlessly integrate into your clinical approach, offering a comprehensive suite of tools to enhance patient self-management.
Digitally Enhanced Pulmonary Rehabilitation (DEPR)
Pulmonary Rehabilitation (PR) is a highly effective therapy for Chronic Obstructive Pulmonary Disease (COPD), improving symptoms, exercise capacity and quality of life.
If PR is given in time, 1-year hospital readmission and mortality rates can be reduced by 50% and 40% respectively.
myCOPD addresses a critical challenge around a lack of access to traditional, in person PR classes:
• Currently, only 3% of patients in the US who are eligible
for PR receive it.
• Low resources, staffing and infrastructure and insurance reimbursement has led to only 1 traditional PR center for every 6,030 individuals with COPD.
Benefits of using myCOPD to support a DEPR approach.
Increased capacity
Choice of fully remote (myCOPD only) or hybrid (myCOPD plus traditional PR) means that more patients receive treatment.
Increased revenue
DEPR enables physician billing to CMS codes which cannot be accessed for traditional PR.
Lower readmission costs
COPD is the 3rd leading cause of readmission in the US - an increase in PR capacity results in admission savings of between $7,000-$15,000 per patient.
Lower readmission costs
COPD is the 3rd leading cause of readmission in the US - an increase in PR capacity results in admission savings of between $7,000-$15,000 per patient.
Trial Evidence.
3 randomised clinical trials and 10 Real World Evaluations.
Real World Evidence:
myCOPD delivers a 100% capacity increase in PR and a higher completion rate relative to a conventional model.
Independent NICE public involvement survey; (8)
82.7% reported myCOPD is easy to use & helped improve understanding of condition & symptoms. 66.1% felt a reduction in number of exacerbations. 74.6% felt confident in managing COPD symptoms after using myCOPD.
Randomised Clinical Trial:
‘Non-inferior’ vs. conventional model relying on face-to-face sessions (6 min walk test, symptom scores).
Testimonials
myCOPD success stories.
“As effective as hospital-based programs.”
Global Strategy for the Diagnosis and Management of COPD (GOLD 2023).
"If pulmonary rehabilitation was a medication, IT WOULD BE A BLOCKBUSTER.”
David Mannino, MD, FCCP, FERS Director, Pulmonary Epidemiology University of Kentucky.
"A ‘business in a box’ that drives practice revenue and provides the best possible care for patients that extends lives, and saves lives.”
myCOPD Customer (US Healthcare Provider).
“The tragedy in the US is that [PR] is only available to such a small percentage."
David Mannino, MD, FCCP, FERS Director, Pulmonary Epidemiology University of Kentucky.
One product, two solutions for optimized COPD management.
myCOPD comes in two forms: myCOPD Essentials , contains the Core Pulmonary Rehabilitation Experience and myCOPD Pro, for full Remote Patient Monitoring.
| myCOPD | Essentials | myCOPD | Pro | |
|---|---|---|
| Home-based pulmonary rehabilitation program | ✔ | ✔ |
| Medication management | ✔ | ✔ |
| Structured education | ✔ | ✔ |
| Administration dashboard to monitor patient engagement | ✔ | ✔ |
| Wearable device activity tracking | ✔ | ✔ |
| Connected medical device (eg. pulse oximeters, B.P. inhaler adherence device) integrations | ✖ | ✔ |
| Clinical dashboard: Remote patient monitoring of Electronic Patient Reported Outcome Measures (EPROM) and medical device data. | ✖ | ✔ |
| Electronic Medical Record (EMR) integrations | ✖ | ✔ |
| Al exacerbation prediction | ✖ | ✔ |
| Digital Health Coach Service | ✖ | ✔ |
